PT - JOURNAL ARTICLE AU - Brauner, Jan M. AU - Mindermann, Sören AU - Sharma, Mrinank AU - Johnston, David AU - Salvatier, John AU - Gavenčiak, Tomáš AU - Stephenson, Anna B. AU - Leech, Gavin AU - Altman, George AU - Mikulik, Vladimir AU - Norman, Alexander John AU - Monrad, Joshua Teperowski AU - Besiroglu, Tamay AU - Ge, Hong AU - Hartwick, Meghan A. AU - Teh, Yee Whye AU - Chindelevitch, Leonid AU - Gal, Yarin AU - Kulveit, Jan TI - The effectiveness of eight nonpharmaceutical interventions against COVID-19 in 41 countries AID - 10.1101/2020.05.28.20116129 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.28.20116129 4099 - http://medrxiv.org/content/early/2020/10/14/2020.05.28.20116129.short 4100 - http://medrxiv.org/content/early/2020/10/14/2020.05.28.20116129.full AB - Governments are attempting to control the COVID-19 pandemic with nonpharmaceutical interventions (NPIs). However, it is still largely unknown how effective different NPIs are at reducing transmission. Data-driven studies can estimate the effectiveness of NPIs while minimising assumptions, but existing analyses lack sufficient data and validation to robustly distinguish the effects of individual NPIs. We gather chronological data on NPIs in 41 countries between January and the end of May 2020, creating the largest public NPI dataset collected with independent double entry. We then estimate the effectiveness of 8 NPIs with a Bayesian hierarchical model by linking NPI implementation dates to national case and death counts. The results are supported by extensive empirical validation, including 11 sensitivity analyses with over 200 experimental conditions. We find that closing schools and universities was highly effective; that banning gatherings and closing high-risk businesses was effective, but closing most other businesses had limited further benefit; and that many countries may have been able to reduce R below 1 without issuing a stay-at-home order.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJan Brauner was supported by the EPSRC Centre for Doctoral Training in Autonomous Intelligent Machines and Systems [EP/S024050/1] and by Cancer Research UK. Soeren Mindermann's funding for graduate studies was from Oxford University and DeepMind. Mrinank Sharma was supported by the EPSRC Centre for Doctoral Training in Autonomous Intelligent Machines and Systems [EP/S024050/1]. Gavin Leech was supported by the UKRI Centre for Doctoral Training in Interactive Artificial Intelligence [EP/S022937/1]. The paid contractor work in the data collection, the development of the interactive website, and the costs for cloud compute were funded by the Berkeley Existential Risk Initiative. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll NPI data with sources and model code are available at https://github.com/epidemics/COVIDNPIs/tree/manuscript https://github.com/epidemics/COVIDNPIs/tree/manuscript